A Unique Neuronal Molecule in the Central Nervous System
by John R. Moffett
N-Acetylaspartate brings together investigators from around the world who are interested in the study of NAA, and the roles it plays in neuronal development and functioning.
Contents
- A Brief Overview of N-Acetylaspartate and N-Acetylaspartylglutamate
- Expression of N-Acetylaspartate and N-Acetylaspartylglutamate in the Nervous System
- N-Acetylaspartate Metabolism in Neural Cells
- NAA Synthesis and Functional Roles
- Identity of the High-Affinity Sodium/Carboxylate Cotransporter NaC3 as the NAA Transporter
- Canvan Disease: Studies on the Knockout Mouse
- Functions of N-Acetylaspartate and N-Acetylaspartylglutamate in Brain: Evidence of a Role in Maintenance of Higher Brain Integrative Activities of Information Processing and Cognition
- Control of Brain Volume During Hypoosmolality and Hyperosmolality
- Physiological Role of N-Acetylaspartate: Contribution to Myelinogenesis
- Defective Myelin Lipid Synthesis as a Pathogenic Mechanism of Canvan Disease
- Mutation Analysis of the Aspartoacylase Gene in Non-Jewish Patients with Canavan Disease
- Does ASPA Gene Mutation in Canavan Disease Alter Oligodendrocyte Development: A Tissue Culture Study of ASPA KO Mice Brain
- Quantitation of NAA in the Brain by Magnetic Resonance Spectroscopy
- N-Acetyl-L-Aspartate in Multiple Sclerosis
- NAA and Higher Cognitive Function in Humans
- In Vivo NMR Measures of NAA and the Neurobiology of Schizophrenia
- N-Acetylaspartate as a Marker of Neuronal Injury in Neurodegenerative Disease
- Regulation of NAA-Synthesis in the Human Brain In Vivo: Canavan's Disease, Alzheimer's Disease and Schizophrenia
- Magnetic Resonance Spectroscopy for Monitoring Neuronal Integrity in Amyotrophic Lateral Sclerosis
- Hypoacetylaspartia: Clinical and Biochemical Follow-Up of a Patient
- Cellular Localization of NAAG
- Synthesis of N-Acetylaspartylglutamate (NAAG) and N-Acetylaspartate (NAA) in Axons and Glia of the Crayfish Medial Giant Nerve Fiber
- NAAG as a Neurotransmitter
- Glutamate Carboxypeptide ASE II (NAALADase) Inhibition as a Novel Therapeutic Strategy
- N-Acetylaspartylglutamate (NAAG) in Spinal Cord Injury and Disease
- N-Acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher Disease
- Concluding Remarks
Index